查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771308

製造執行系統市場：行業趨勢和全球預測 - 依部署類型、最終用戶和主要區域

Manufacturing Execution System Market: Industry Trends and Global Forecasts - Distribution by Type of Deployment, Type of End-User and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

全球製造執行系統市場：概覽

預計到2035年，全球製造執行系統市場規模將從目前的39.9億美元成長至204.6億美元，預測期內年複合成長率為 16.02%。

市場區隔包括按以下參數細分的市場規模和市場機會：

部署類型

  • 雲端
  • 企業資料中心
  • 混合雲
  • 本地部署

最終使用者

  • 生命科學/生技公司
  • 醫療器材供應商
  • 製藥公司其他

主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和北非

全球製造執行系統市場：成長與趨勢

多年來，醫療保健產業取得了顯著成長，製造商必須採用新技術和工具，才能在不斷變化的市場格局中保持競爭力。製造執行系統在醫療保健產業獲得長期競爭優勢方面發揮關鍵作用。製造執行系統是一個動態資訊系統，可以連接、監控和同步複雜製造作業中的各種流程。 MES系統可以提高工廠的生產力和效率，同時讓整個製造流程更加靈活和敏捷。它們還簡化了遵守法規指南的流程，使醫療保健公司更容易在製造過程中保持高品質標準。

製造執行系統市場-IMG1

近年來，許多醫療保健產業的利害關係人積極致力於將製造執行系統融入其生產線。此外，該領域的公司整合物聯網（IoT）和人工智慧（AI）等先進技術，以收集和分析來自各種來源的大量資料，以洞察、預測和行動的形式創造價值。隨著醫療保健產業轉向製造執行系統，在生產線上做出資料驅動的決策，未來的工業流程有望實現更高的效率和更好的成長機會。

全球製造執行系統市場：關鍵洞察

本報告深入探討了全球製造執行系統市場的現狀，並識別了該行業的潛在成長機會。主要調查結果包括：

  • 目前，全球超過 75 家公司聲稱提供製造執行系統（MES），用於監控、追蹤和控制醫療保健產業的生產流程。
  • 利害關係人透過各種授權模式，為製藥、生命科學/生物技術和醫療器材產業提供與多種軟體整合的MES。
  • 超過 85%的MES 供應商以訂閱模式提供服務，醫療器材產業成為此類服務的主要最終用戶。
  • ERP 和 PLM 已成為最突出的整合軟體，近 50%的利害關係人提供與多種軟體整合的MES。
  • 近 15%的利害關係人聲稱向所有最終用戶提供 MES，其中一些主要的例子包括 Atachi Systems、Dassault Systemes、Epicor、GE Digital、Infor、Tulip 等。
  • 為了滿足全球客戶不斷變化的需求，利害關係人向不同的地區擴張。
製造執行系統市場-IMG2
  • 利害關係人日益成長的興趣也體現在合作活動的增加上，事實上，過去兩年聯盟數量創歷史新高。
  • 為了建立競爭優勢，製造執行系統供應商積極升級現有能力，以進一步增強各自的服務/產品。
  • 專有的價值創造框架重點介紹了該領域新興參與者必須整合的關鍵工具和技術，以增強其MES產品組合。
  • 預計未來十年市場將以超過16%的健康速度成長，機會將遍布不同的部署類型、最終用戶和不同地區。
製造執行系統市場-IMG3

全球製造執行系統市場：關鍵細分市場

根據部署類型，市場分為雲端部署、企業資料中心部署、混合部署和本地部署。目前，由於對基於雲端的MES解決方案的需求不斷成長，雲端部署佔據全球製造執行系統市場的最大佔有率（約69%）。然而，預計在預測期內，混合部署市場的年複合成長率將更高。

根據最終用戶類型，市場細分為生命科學/生技公司、醫療設備提供者、製藥公司和其他。目前，醫療器材供應商佔據製造執行系統（MES）市場最高佔有率（約 51%）。此外，生命科學/生物技術公司由於高度依賴 MES 輔助批量生產管理、物料和產品的追蹤和追溯，其年複合成長率可能相對較高。

根據主要地區，市場細分為北美、歐洲、亞太地區、中東和非洲、拉丁美洲以及世界其他地區。目前，歐洲（約 41%）在製造執行系統市場佔據主導地位，佔據最大的收入佔有率。然而，亞太地區市場預計在預測期內的年複合成長率將更高，達到 16.8%。

參與製造執行系統市場的公司範例

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

本報告調查製造執行系統市場，提供市場概述，以及依部署類型、最終用戶和地區的趨勢，和參與市場的公司簡介。

目錄

第1章 簡介

第2章 執行摘要

第3章 簡介

  • 製造執行系統概述
  • 製造執行系統的核心功能
  • 製造執行系統的實施模型
  • 製造執行系統所帶來的優勢
  • 製造執行系統面臨的挑戰
  • 為不同業務整合製造執行系統
  • 結論

第4章 市場格局

第4章 醫療保健領域的製造執行系統提供者：市場概覽

  • 製造執行系統清單醫療健康領域的執行系統提供者
  • 依成立年份分析
  • 依公司規模分析
  • 依總部位置分析
  • 依部署類型分析
  • 依軟體整合分析
  • 依許可證類型分析
  • 依最終使用者類型分析
  • 依關鍵功能分析
  • 依提供的服務類型分析
  • 依照所獲得的品質認證分析

第5章 關鍵洞察

第6章 合作夥伴關係與協作

第7章 競爭分析

  • 醫療健康領域的製造執行系統提供者：競爭分析
  • 假設和關鍵參數
  • 研究方法
  • 投資組合實力基準測試
  • 合作夥伴活動基準測試
  • 競爭分析：超大型公司
  • 競爭分析：大型公司
  • 競爭分析：中型公司
  • 競爭分析：小型公司

第8章 公司簡介

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

第9章 價值創造架構：解決製造執行系統未滿足需求的策略指南

  • 醫療保健產業對製造業執行系統的未滿足需求
  • 關鍵假設與研究方法
  • 關鍵工具與技術
  • 創新程度及相關風險
  • 結論

第10章 市場預測

  • 關鍵假設及預測研究方法
  • 預測的細分市場
  • 醫療保健市場的製造執行系統提供者（～2035年）
  • 醫療保健市場的製造執行系統提供者：依部署類型分析（～2035年）
  • 醫療保健市場的製造執行系統提供者：依最終用戶分析（～2035年）
  • 醫療保健市場的製造執行系統提供者：依地區分析（～2035年）

第11章 高層洞察

第12章 附錄1：附加圖表

第13章 附錄2：表格資料

第14章 附錄3：公司列表

Product Code: RA100374

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: OVERVIEW

As per Roots Analysis, the global manufacturing execution system market is estimated to grow from USD 3.99 billion in the current year to USD 20.46 billion by 2035, at a CAGR of 16.02% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Deployment

  • Cloud
  • Corporate Data Center
  • Hybrid
  • On Premise

Type of End-User

  • Life Science / Biotechnology Companies
  • Medical Device Providers
  • Pharmaceutical Companies and Others

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: GROWTH AND TRENDS

Over the years, the healthcare industry has undergone substantial growth, making it essential for manufacturers to adopt new technologies and tools in order to remain relevant and competitive in the evolving market landscape. Manufacturing execution systems play a crucial role in achieving long term competitive advantages in the healthcare industry. Manufacturing execution system is a dynamic information system that connects, monitors, and synchronizes various processes of complex manufacturing processes. MES system enables enhanced plant productivity and efficiency along with increased flexibility and agility across the manufacturing processes. It also simplifies the process of complying with regulatory guidelines and facilitates healthcare companies in maintaining high quality standards during the production process.

Manufacturing Execution System Market - IMG1

In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate manufacturing execution systems into their production lines. In addition, players engaged in this domain are integrating advanced technologies, including internet of thing (IOT) and artificial intelligence (AI) to collect and analyze large volume of data from various sources and to produce value in the form of insights, predictions, and actions. With the healthcare industry turning towards manufacturing execution systems to make data-driven decisions about their production lines, the future of industrial processes promises greater efficiency and better opportunities for growth.

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY INSIGHTS

The report delves into the current state of the global manufacturing execution system market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • At present, more than 75 companies across the globe claim to offer manufacturing execution systems (MES) in order to monitor, track and control the production process in the healthcare sector.
  • Stakeholders are offering MES, integrated with numerous types of software, through different licensing models to serve the pharmaceutical, life science / biotechnology and medical device industries.
  • Over 85% of the MES providers offer such services via subscription models; the medical device industry has emerged as a prominent end user for such services.
  • ERP and PLM have emerged as the most prominent integration software; nearly 50% of stakeholders offer MES integrated with more than one type of software.
  • Nearly 15% stakeholders claim to offer MES for all end users; prominent examples include Atachi Systems, Dassault Systemes, Epicor, GE Digital, Infor and Tulip.
  • In order to cater to the evolving needs of clients across the world, stakeholders have established a presence across different regions; Europe has emerged as the key hub, featuring the highest number of MES providers.
Manufacturing Execution System Market - IMG2
  • The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, the maximum number of collaborations were inked in the last two years.
  • In pursuit of building a competitive edge, manufacturing execution system providers are actively upgrading their existing capabilities to further enhance their respective service / product offerings.
  • Our proprietary value creation framework highlights the key tools and technologies that emerging players in this domain must integrate in order to augment their MES portfolio.
  • The market is expected to witness a healthy growth of over 16% in the coming decade; the opportunity is likely to be well distributed across various type of deployments, end users and different regions.
Manufacturing Execution System Market - IMG3

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY SEGMENTS

Cloud Segment Occupies the Largest Share of the Manufacturing Execution System Market

Based on the type of deployment, the market is segmented into cloud, corporate datacenter, hybrid and on-premises. At present, the cloud segment holds the maximum (~69%) share of the global manufacturing execution system market due to the growing demand for cloud-based MES solutions. However, the hybrid segment is expected to grow at a higher CAGR during the forecast period.

By Type of End-User, Life Science / Biotechnology Companies is the Fastest Growing Segment of the Global Manufacturing Execution System Market

Based on the type of end-user, the market is segmented into life science / biotechnology companies, medical device providers, pharmaceutical companies and others. Currently, the medical device providers segment captures the highest proportion (~51%) of the manufacturing execution system market. Further, the life science / biotechnology companies' segment is likely to grow at a relatively higher CAGR as the companies highly rely on MES that aid in managing batch production, tracking, and tracing materials and products.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and the rest of the world. Currently, Europe (~41%) dominates the manufacturing execution system market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 16.8% during the forecast period.

Example Players in the Manufacturing Execution System Market

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

PRIMARY RESEARCH OVERVIEW

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews conducted with the following industry stakeholders:

  • Chief Executive Officer, Company A
  • Chief Marketing Officer, Company B
  • Director of Sales, Company C

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global manufacturing execution system market, focusing on key market segments, including [A] type of deployment, [B] type of end-user and [C] key geographical regions.
  • Market Landscape: A comprehensive evaluation of manufacturing execution system companies in the healthcare industry, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of deployment, [E] integrating MES software, [F] type of license, [G] type of end-user, [H] key features, [I] type of service(s) offered and [J] quality certifications received.
  • Key Insights: An in-depth analysis of manufacturing execution system market trends using five schematic representations, including [A] a detailed analysis, based on year of establishment and region of headquarters, [B] an analysis, based on company size and type of deployment, [C] a comprehensive analysis, based on type of license and end-user, [D] an analysis, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in MES market.
  • Partnerships and Collaborations: An in-depth analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] key players (in terms of the number of partnerships signed) and [E] geographical distribution of partnership activity.
  • Company Competitiveness Analysis: An insightful competitive analysis of manufacturing execution system providers in the healthcare industry, examining factors, such as [A] product portfolio strength, [B] competitive index and [C] partnership strength.
  • Company Profiles: In-depth profiles of companies engaged in the manufacturing execution system industry, focusing on [A] company overview and [B] recent developments and an informed future outlook.
  • Value Creation Framework: An insightful framework depicting the implementation of several advanced tools and technologies, such as [A] artificial intelligence, [B] cloud computing, [C] internet of things and [D] machine learning.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Overview of Manufacturing Execution Systems
  • 3.2. Core Function of Manufacturing Execution Systems
  • 3.3. Deployment Models of Manufacturing Execution Systems
  • 3.4. Benefits Offered by Manufacturing Execution Systems
  • 3.5. Challenges Associated with Manufacturing Execution Systems
  • 3.6. Integration of Manufacturing Execution Systems for Different Operations
  • 3.7. Concluding Remarks

4. MARKET LANDSCAPE

4.1. Manufacturing Execution System Providers in Healthcare: Market Overview

  • 4.2. List of Manufacturing Execution System Providers in Healthcare
  • 4.3. Analysis by Year of Establishment
  • 4.4. Analysis by Company Size
  • 4.5. Analysis by Location of Headquarters
  • 4.6. Analysis by Type of Deployment
  • 4.7. Analysis by Integrating Software
  • 4.8. Analysis by Type of License
  • 4.9. Analysis by Type of End User
  • 4.10. Analysis by Key Features
  • 4.11. Analysis by Type of Service(s) Offered
  • 4.12. Analysis by Quality Certifications Received

5. KEY INSIGHTS

  • 5.1. Analysis by Year of Establishment and Region of Headquarters
  • 5.2. Analysis by Company Size and Type of Deployment
  • 5.3. Analysis by Type of License and End User
  • 5.4. Analysis by Company Size and Key Features
  • 5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)

6. PARTNERSHIPS AND COLLABORATIONS

  • 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
  • 6.2. Analysis by Year of Partnership
  • 6.3. Analysis by Type of Partnership
  • 6.4. Analysis by Year of Partnership and Type of Partnership
  • 6.5. Analysis by Type of Partnership and Company Size
  • 6.6. Key Players: Analysis by Number of Partnerships
  • 6.7. Analysis by Type of Partner
  • 6.8. Analysis by Country
  • 6.9. Analysis by Region
  • 6.10. Intercontinental and Intracontinental Deals
  • 6.11. Analysis by Location of Headquarters of Partner
  • 6.12. Analysis by Type of Partnership and Location of Headquarters of Partner

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology
  • 7.4. Benchmarking of Portfolio Strength
  • 7.5. Benchmarking of Partnership Activity
  • 7.6. Company Competitiveness Analysis: Very Large Players
  • 7.7. Company Competitiveness Analysis: Large Players
  • 7.8. Company Competitiveness Analysis: Mid-Sized Players
  • 7.9. Company Competitiveness Analysis: Small Players

8. COMPANY PROFILES

  • 8.1. Andea
    • 8.1.1. Company Overview
    • 8.1.2. Technology Portfolio
    • 8.1.3. Recent Developments and Future Outlook
  • 8.2. Critical Manufacturing
    • 8.2.1. Company Overview
    • 8.2.2. Technology Portfolio
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Dassault Systemes
    • 8.3.1. Company Overview
    • 8.3.2. Technology Portfolio
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. GE Digital
    • 8.4.1. Company Overview
    • 8.4.2. Technology Portfolio
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Infor
    • 8.5.1. Company Overview
    • 8.5.2. Technology Portfolio
    • 8.5.3. Recent Developments and Future Outlook
  • 8.6. Korber
    • 8.6.1. Company Overview
    • 8.6.2. Technology Portfolio
    • 8.6.3. Recent Developments and Future Outlook
  • 8.7. Rockwell Automation
    • 8.7.1. Company Overview
    • 8.7.2. Technology Portfolio
    • 8.7.3. Recent Developments and Future Outlook

9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS

  • 9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
  • 9.2. Key Assumptions and Methodology
  • 9.3. Key Tools and Technologies
    • 9.3.1. Technology 1
    • 9.3.2. Technology 2
    • 9.3.3. Technology 3
    • 9.3.4. Technology 4
  • 9.4. Extent of Innovation versus Associated Risks
  • 9.5. Concluding Remarks

10. MARKET FORECAST

  • 10.1. Key Assumptions and Forecast Methodology
  • 10.2. Forecasted Market Segments
  • 10.3. Manufacturing Execution System Providers in Healthcare Market, Till 2035
  • 10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, Till 2035
    • 10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
    • 10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
    • 10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
    • 10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions
  • 10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, Till 2035
    • 10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
    • 10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
    • 10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
    • 10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users
  • 10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, Till 2035
    • 10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
    • 10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
    • 10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
    • 10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
    • 10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
    • 10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035

11. EXECUTIVE INSIGHTS

  • 11.1. Company A
    • 11.1.1. Company Snapshot
    • 11.1.2. Interview Transcript: Chief Executive Officer
  • 11.2. Company B
    • 11.2.1. Company Snapshot
    • 11.2.2. Interview Transcript: Chief Marketing Officer
  • 11.3. Company C
    • 11.3.1. Company Snapshot
    • 11.3.2. Interview Transcript: Director of Sales

12. APPENDICES I: OTHER FIGURES

12.1. Market Overview

  • 12.2. Key Insights
  • 12.3. Partnerships and Collaborations
  • 12.4. List of Figures

13. APPENDICES II: TABULATED DATA

14. APPENDICES III: LIST OF COMPANIES

List of Tables

  • Table 4.1. Manufacturing Execution System Providers in Healthcare: Information on Year of Establishment, Headquarters, Company Size and Name of Solution
  • Table 4.2. Manufacturing Execution System Providers in Healthcare: Information on Type of Deployment, Integrating Software, Type of License, Type of End User, Key Features, Type of Service(s) Offered and Quality Certifications Received
  • Table 4.3. Manufacturing Execution System Providers in Healthcare: Key Features, Type of Service(s) Offered and Quality Certifications Received
  • Table 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
  • Table 13.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
  • Table 13.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
  • Table 13.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
  • Table 13.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
  • Table 13.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
  • Table 13.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
  • Table 13.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
  • Table 13.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
  • Table 13.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
  • Table 13.10. Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 13.11. Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 13.12. Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 13.13. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Table 13.14. Partnerships and Collaborations: Key Players by Number of Partnerships
  • Table 13.15. Partnerships and Collaborations: Distribution by Type of Partner
  • Table 13.16. Partnerships and Collaborations: Distribution by Country
  • Table 13.17. Partnerships and Collaborations: Distribution by Region
  • Table 13.18. Intercontinental and Intracontinental Deals
  • Table 13.19. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, Till 2035
  • Table 13.20. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
  • Table 13.21. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
  • Table 13.22. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
  • Table 13.23. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
  • Table 13.24. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, Till 2035
  • Table 13.25. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
  • Table 13.26. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
  • Table 13.27. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
  • Table 13.28. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
  • Table 13.29. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, Till 2035
  • Table 13.30. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
  • Table 13.31. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
  • Table 13.32. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
  • Table 13.33. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
  • Table 13.34. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
  • Table 13.35. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035

List of Figures

  • Figure 3.4. Integration of Manufacturing Execution Systems for Different Operations
  • Figure 4.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
  • Figure 4.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
  • Figure 4.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
  • Figure 4.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
  • Figure 4.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
  • Figure 4.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
  • Figure 4.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
  • Figure 4.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
  • Figure 4.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
  • Figure 5.1. Key Insights: Distribution by Year of Establishment and Region of Headquarters
  • Figure 5.2. Key Insights: Distribution by Company Size and Type of Deployment
  • Figure 5.3. Key Insights: Distribution by Type of License and End User
  • Figure 5.4. Key Insights: Distribution by Company Size and Key Features
  • Figure 5.5. Key Insights: Distribution by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received
  • Figure 6.1. Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 6.2. Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 6.3. Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 6.4. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Figure 6.5. Partnerships and Collaborations: Key Players by Number of Partnerships
  • Figure 6.6. Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 6.7. Partnerships and Collaborations: Distribution by Country
  • Figure 6.8. Partnerships and Collaborations: Distribution by Region
  • Figure 6.9. Intercontinental and Intracontinental Deals
  • Figure 7.1. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
  • Figure 7.2. Company Competitiveness Analysis: Benchmarking of Partnership Activity
  • Figure 7.3. Company Competitiveness Analysis: Very Large Players
  • Figure 7.4. Company Competitiveness Analysis: Large Players
  • Figure 7.5. Company Competitiveness Analysis: Mid-Sized Players
  • Figure 7.6. Company Competitiveness Analysis: Small Players
  • Figure 9.1. Value Creation Framework: Trends in Research Activity related to Integration of Key Tools and Technologies with Manufacturing Execution System
  • Figure 9.2. Value Creation Framework: Trends in Intellectual Property related to Integration of Key Tools and Technologies with Manufacturing Execution System
  • Figure 9.3. Value Creation Framework: Extent of Innovation versus Associated Risk Matrix
  • Figure 9.4. Value Creation Framework: Comparison of Key Tools / Technologies
  • Figure 10.1. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, Till 2035
  • Figure 10.2. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
  • Figure 10.3. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
  • Figure 10.4. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
  • Figure 10.5. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
  • Figure 10.6. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, Till 2035
  • Figure 10.7. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
  • Figure 10.8. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
  • Figure 10.9. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
  • Figure 10.10. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
  • Figure 10.11. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, Till 2035
  • Figure 10.12. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
  • Figure 10.13. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
  • Figure 10.14. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
  • Figure 10.15. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
  • Figure 10.16. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
  • Figure 10.17. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035